In Japan, the forecast for respiratory system medicine sales from 2024 to 2028 indicates a stagnant trend, with the sales value consistently representing 1.5 of Total Sales. This suggests no expected year-on-year growth or decline as the sales value remains constant across the years.

Future trends to watch for:

Potential market disruptions from new regulations or changes in healthcare policies.
Developments in technology and innovation in respiratory treatments could influence market dynamics.
Demographic changes or shifts in population health demands, particularly with regard to aging populace and prevalence of chronic conditions.